510(k) · Cleared
ClearedCidex Opa Concentrate
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Advanced Sterilization Products · MED Sterilant, Medical Devices
Cleared on Apr 4, 2005 as substantially equivalent to K991487 (Advanced Sterilization Products, 1999) and 1 other predicate after a 559-day review. Its family tree reaches back 1 generation to 1988.
- Decided
- Apr 4, 2005
- Review
- 559 days
- Class
- Class II
- Product code
- MED
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 1 generation to K875280 (1988). 2 ancestors in all. No later device cites it as a predicate yet.
- Root · 1 generation backK875280 Steris System 1 Processor and 20 SterilantSteris C/O Medical Device Consultants, Inc. · 1988 · Recalled
- This deviceK032959 Cidex Opa ConcentrateAdvanced Sterilization Products · 2005
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K875280 | Steris System 1 Processor and 20 Sterilant | Steris C/O Medical Device Consultants, Inc. | 1988 | 3 |
| 0 (this device) | K032959 | Cidex Opa Concentrate | Advanced Sterilization Products | 2005 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1999 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MED? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new MED device
- #1 K251666 SYSTEM 1E Liquid Chemical Sterilant Processing…score 13.8 · 10 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K991487 | Cidex Opa SolutionSummary page 1…CIDEX*' OPA Concentrate In-Use solution claims equivalence to the device following legally marketed medical devices: CIDEX®" OPA Solution (K99 1487) and Steris 2OTM Sterilant/ Steris System ITM (K875280) Device CIDEX' OPA Concentrate is formulated to contain 5.75… | 1999 |
| * | K875280 | Steris System 1 Processor and 20 SterilantSummary page 1…ce to the device following legally marketed medical devices: CIDEX®" OPA Solution (K99 1487) and Steris 2OTM Sterilant/ Steris System ITM (K875280) Device CIDEX' OPA Concentrate is formulated to contain 5.75% w/v of description ortho-phthalaldehyde. The r… | 1988 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- 1 of the 2 ancestors has a recall of any class.
- 2 other devices also cite its predicate K991487.
How does its category compare?
All MED devicesMED Sterilant, Medical Devices: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · MED
2in 2023
2026 to Oct 25, outlined.
Median 510(k) review, days · MED
84in 2019
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · MED
2in 2011
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · MED
9in 2025
MAUDE reports naming product code MED, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 3 | 34 |
| 2008 | 1 | — | 2 | 79 |
| 2009 | 0 | — | 0 | 158 |
| 2010 | 6 | 281 | 0 | 89 |
| 2011 | 0 | — | 2 | 106 |
| 2012 | 3 | 111 | 0 | 337 |
| 2013 | 1 | — | 0 | 140 |
| 2014 | 1 | — | 0 | 105 |
| 2015 | 0 | — | 0 | 110 |
| 2016 | 1 | — | 0 | 135 |
| 2017 | 1 | — | 0 | 74 |
| 2018 | 2 | — | 0 | 42 |
| 2019 | 4 | 84 | 0 | 35 |
| 2020 | 0 | — | 0 | 32 |
| 2021 | 2 | — | 0 | 31 |
| 2022 | 1 | — | 0 | 16 |
| 2023 | 2 | — | 0 | 9 |
| 2024 | 0 | — | 0 | 8 |
| 2025 | 0 | — | 0 | 9 |
| 2026 | 2 | — | 0 | — |
What is it indicated for?
CIDEX® OPA Concentrate is a high level disinfectant (HLD) at the minimum IN USE concentration of 0.055% with a contact time of 5 minutes at 50°C for reprocessing heat sensitive (<60°C) semi-critical endoscopes when used according to the Directions for Use.
CIDEX® OPA Concentrate is intended for use in the ASP EvoTech™ System. THIS PRODUCT IS NOT INTENDED FOR MANUAL USE. See Directions for Use.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K032959 · printed Nov 5, 2026
Cite this page
510(k) Report. “K032959: Cidex Opa Concentrate.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K032959
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026